May 01, 2025

Health Care Faces New Immigration Reality

Health care facilities face new challenges as sensitive locations policy protecting them from immigration enforcement was rescinded in January 2025, requiring new protocols for patient protection.

Conexiant

May 01, 2025

Explore the latest in retinal disorder research and treatment at the global Retina World Congress, where leading experts share best practices and advancements.

Retinal Physician

May 01, 2025

Spotlight on Technology & Technique: LYNX LIO Offers Pattern Delivery and Portability

Discover the revolutionary LYNX, a laser indirect ophthalmoscope providing mobile, precise, and comfortable retinal treatments with integrated headset and wireless tablet interface.

Ophthalmology Management

April 30, 2025

FDA Approves FcRn Blocker for Broad gMG Use

The first FcRn blocker for both adult and pediatric generalized myasthenia gravis has been approved by the FDA, based on data showing sustained symptom improvement and IgG reduction in clinical trials.

Conexiant

April 29, 2025

New Oral Option Approved for GCA

The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 21, 2025

Transfusion Strategy Outcomes After Aneurysmal SAH Similar, Study Reveals

SAHaRA trial investigators compared a liberal (transfusion at hemoglobin levels of 10 g/dL or lower) and a restrictive (transfusion at 8 g/dL or lower) red-cell tranfusion strategy among critically ill patients with acute aneurysmal subarachnoid hemorrhage (SAH) and anemia.

Conexiant

April 18, 2025

Intranasal Diazepam Gains Expanded Approval for Pediatric Patients

“Approval of an immediate-use intranasal diazepam treatment that can be given at any time—even while a child is actively seizing—in this young age group is an important advance for the epilepsy community.”

Conexiant

April 17, 2025

iPSC-Derived Cells Show Promise for Parkinson's

A phase I/II trial demonstrated that allogeneic iPSC-derived dopaminergic progenitors survived, produced dopamine, and did not form tumors.

Conexiant